Transformation is never a simple or fast process, especially in the biopharmaceutical industry. Yet, transformative events are integral to generating new therapeutics that have the potential to aid thousand or even millions of lives. Transformation in science can happen on many fronts, and Biopharma 4.0 was put into place to tackle the aging manufacturing process by applying new digital tools and data analytics to understand production workflows better and ensure greater product consistency, safety, and efficacy. Take a listen to this GENcast, where we sit down with two scientists from Merck to see what goals have been met for the adoption of Biopharma 4.0 and what hurdles still need to be cleared.
Panelists:
Dr. Geoffrey Rule
Principal Scientist
Merck
Dr. Lee Madrid
Head of Global Biopharm Center of Excellence
Merck
